The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
16 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,990,346 in first-year total cost, median $489,645.
Most frequent study sections
- Oral, Dental and Craniofacial Sciences Study Section[ODCS]5
- Special Emphasis Panel[ZRG1 OTC-M (08)]2
- Biomaterials and Biointerfaces Study Section[BMBI]1
- Immunity and Host Defense Study Section[IHD]1
- Nanotechnology Study Section[NANO]1
Most frequent institutions
- MEDICAL UNIVERSITY OF SOUTH CAROLINA2
- TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR2
- UNIVERSITY OF MICHIGAN AT ANN ARBOR2
- DUKE UNIVERSITY1
- LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Immunometabolic Regulation of MDSCs in Periodontitis1R01DE032310-01 | KIRKWOOD, KEITH L | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | $677,805 | ODCS |
| 2022 | Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer1R01DE032018-01 | AMIT, MORANCALIN, GEORGE A. | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $673,034 | ZRG1 |
| 2022 | Engineered Nano-formulations for STING Activation1R01DE031951-01A1 | LEI, YU LEOMOON, JAMES J. | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $574,732 | NANO |
| 2022 | Oral commensal fungi and structural immunity1R01DE031382-01A1 | SWIDERGALL, MARC | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER, CA | $519,964 | IHD |
| 2022 | Targeting the innate immune response in HNSCC2R01DE027325-06 | VARNER, JUDITH A | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $498,386 | ZRG1 |
| 2022 | Deciphering Macrophage Phenotype and Function in Disc Herniation and associated Back/leg Pain1R01AR078888-01A1 | LI, XUDONG J. | UNIVERSITY OF VIRGINIA, VA | $480,903 | SBSR |
| 2022 | Therapeutic mechanisms of iPSC-MSC derived extracellular vesicles on dry mouth caused by Sjorgren's syndrome or radiotherapy1R56DE032028-01 | LEE, RYANG HWALIU, FEI | TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR, TX | $359,813 | ODCS |
| 2021 | New Engineering Strategy for Harnessing Immune System against Head and Neck Cancer1R01DE030691-01A1 | LEI, YU LEOMOON, JAMES J. | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $584,137 | BMBI |
| 2021 | The role of Galectin-1 in shaping the immune suppressive landscape in head and neck cancer1R01DE029672-01A1 | LE, QUYNH-THU XUAN | STANFORD UNIVERSITY, CA | $574,961 | RTB |
| 2021 | Role of Notch-1/PLA2-IIA in oral dysbiosis, inflammation, and periodontal disease1R01DE029498-01A1 | GONZALEZ, OCTAVIO ALBERTO | UNIVERSITY OF KENTUCKY, KY | $555,461 | ODCS |
| 2021 | Defining the Mechanisms of Epstein-Barr Virus Persistence and Recurrence2R01DE025994-06 | LUFTIG, MICAH A. | DUKE UNIVERSITY, NC | $467,077 | ZRG1 |
| 2021 | SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy1R01DE030140-01 | YOUNG, SIMON | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $428,440 | ZRG1 |
| 2021 | Roles of resident macrophages in salivary gland development, homeostasis, regeneration, and function restoration after radiotherapy1R01DE031478-01 | LIU, FEI | TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR, TX | $359,813 | ODCS |
| 2020 | Intersections of RNA-binding proteins and T-cells in oral epithelial plasticity1R01DE030013-01 | MEHROTRA, SHIKHARPALANISAMY, VISWANATHAN | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $454,933 | ZRG1 |
| 2020 | Mechanistic probes to study the immune response in periodontal disease1R01DE029637-01A1 | WOSTER, PATRICK M | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $396,137 | ZRG1 |
| 2020 | IL-22, Immune Plasticity, and Autotherapy in the Periodontium1R01DE029436-01 | HAJISHENGALLIS, GEORGIOS | UNIVERSITY OF PENNSYLVANIA, PA | $384,750 | ODCS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.